Beranda500420 • BOM
add
Torrent Pharmaceuticals Ltd
Tutup sebelumnya
₹3.359,50
Rentang hari
₹3.336,00 - ₹3.381,95
Rentang tahun
₹2.430,15 - ₹3.589,95
Kapitalisasi pasar
1,13Â T INR
Volume Rata-Rata
4,55Â rb
Rasio P/E
60,85
Hasil dividen
0,96%
Bursa utama
NSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 28,09Â M | 2,82% |
Biaya operasional | 14,21Â M | 3,05% |
Laba bersih | 5,03Â M | 13,54% |
Margin laba bersih | 17,91 | 10,42% |
Penghasilan per saham | 14,88 | 32,00% |
EBITDA | 9,03Â M | 9,92% |
Tarif pajak efektif | 27,21% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 12,35Â M | 56,33% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 75,04 M | — |
Saham yang beredar | 338,04 jt | — |
Harga terhadap nilai buku | 15,17 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 16,82% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 5,03Â M | 13,54% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
Didirikan
1959
Kantor pusat
Situs
Karyawan
15.718
